Elevance Health, Inc. held its 2026 Annual Meeting of Shareholders on May 13, where all three director nominees were elected, executive compensation was approved, the auditor appointment was ratified, and a shareholder proposal on political contributions was rejected.
Key takeaways
Three director nominees—Gail K. Boudreaux, Robert L. Dixon, Jr., and Deanna D. Strable—elected to three-year terms expiring in 2029 with strong majority support over 97% For votes.
Advisory vote approved executive compensation with 92.9% For votes, signaling shareholder alignment with pay practices.
Ratification of Ernst & Young LLP as auditor for fiscal year ending December 31, 2026 passed with 89.3% For votes.
Shareholder proposal for independent study on prohibiting contributions to partisan 527 groups rejected with only 8.7% For votes.
194,441,339 shares represented at the meeting, constituting a quorum.